Daniel Griffin provides a clinical update on COVID-19, then we review an Ad5 vectored SARS-CoV-2 vaccine, reports on remdesivir and hydroxychloroquine, a drug repurposing study, why some patients infect many others, reducing viral transmission, and much more, including listener email.

Guest: Daniel Griffin and Chuck Knirsch

Links for This Episode

• Safety of Ad5 vectored COVID-19 vaccine (Lancet) 43:04
• Analysis of hydroxychloroquine use (Lancet) 50:14
• Remdesivir study (NEJM) 52:55
• Ancient COVID-19 history (MMWR) 55:06
• Drug repurposing for COVID-19 (bioRxiv) 57:00
• Why do few COVID-19 patients infect others? (Science) 1:00:57
• Overdispersion in COVID-19 transmission (Wellcome Open Res) 1:05:13
• Reducing airborne transmission (Science) 1:06:21
• Image credit
• Letters read on TWiV 621 31:54, 37:38, 41:09. 1:10:28
• Timestamps by Jolene. Thanks!

Become a patron of TWiV!

Intro music is by Ronald Jenkees.

Send your virology questions and comments to twiv@microbe.tv

• COVID-19
• Podcast
• Host-Microbe Biology